APP and early-onset autosomal dominant Alzheimer disease: For instance, in Alzheimer’s disease miR-143-3p inhibits amyloid precursor protein (APP) phosphorylation and beta-amyloid (Aβ) generation by targeting death-associated protein kinase 1 (DAPK1) [14].